Comparison of LTA in Patients with Bleeding Disorder of Unknown Cause and Healthy Blood Donors – Now on RPTH Journal
RPTH Journal shared a post on LinkedIn:
“A new study reassesses guideline-recommended agonist concentrations for light transmission aggregometry (LTA). By comparing individuals with bleeding disorder of unknown cause to healthy donors, the work from Lena-Theresa Fanenbruck highlights important considerations for interpreting LTA results in clinical practice.
Read the full article in RPTH for the full analysis and implications for testing standards.”
Ttile: Comparison of light transmission aggregometry in patients with bleeding disorder of unknown cause and healthy blood donors
Authors: Lena-Theresa Fanenbruck, Michael Metze, Maria Weise, Martin Federbusch, Roland Siegemund, Martin Reinhard Henschler, Annelie Siegemund, Sirak Petros, Christian Pfrepper
Get the latest insights on Hemostasis Today.
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins
-
Jul 4, 2026, 15:41Emmanuel J. Favaloro: New Research Highlights Benchmarks for Low Molecular Weight Heparin Monitoring
-
Jul 4, 2026, 15:38Roshni Kulkarni: Maternal Mortality In Bleeding Disorders
-
Jul 4, 2026, 15:34Alejandro González Veliz: Does Elevated Lp(a) Always Mean the Same Cardiovascular Risk?
-
Jul 4, 2026, 15:20Bruno Pougault: Heparin Monitoring Remains One of the Most Challenging Areas in Laboratory Hemostasis